Article

Supreme Court: Decision Nears on 'Obamacare'

The Supreme Court is expected to announce its ruling on the Affordable Care Act (ACA) this month, and with the countdown started speculation about the impact of that decision is heating up on both sides of the "Obamacare" debate.

And both sides predict disaster for doctors -- massive disruption if the law is struck down -- or if it is upheld.

Read the full story: http://hcp.lv/LxGSAe

Source: MedPage Today

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Marry Vuong, PharmD, BCPPS
Screenshot of a webinar panel discussion with Viet Le, PA-C; Nathan Wong, PhD, MPH; Alison Bailey, MD; and Martha Gulati, MD, MS
Mehmet Oz, MD, MBA
Ayodeji Adegunsoye, MD, PhD, MSc
Marilyn Glassberg, MD
Interview with Miriam Freimer, MD, The Ohio State University Wexner Medical Center
Merrill H. Stewart, MD
Rachel Rohaidy, MD
Mansi Shah, MD
Mansi Shah, MD
Related Content
Woman eating burger, fries, and drink | Image credit: korchemkin – stock.adobe.com
August 6th 2025

Most Americans Say Fast Food Doesn’t Belong in Hospitals

Hayden E. Klein
A national poll found the majority of Americans believe hospitals should neither sell nor profit from fast food, with strong support for healthier food environments in medical settings.
Managed Care Cast
August 6th 2025

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Giuliana Grossi Sadie Dobrozsi, MD, MS Interview by Mary Caffrey
Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization
atopic dermatitis | Image Credit: © wladimir1804-stock.adobe.com
August 6th 2025

Long-Term Lebrikizumab Provides Sustained Skin Clearance in Atopic Dermatitis

Maggie L. Shaw
In this subanalysis of data from the ADjoin trial of lebrikizumab, the interleukin-13 receptor inhibitor that is also a monoclonal antibody showed itself to be effective over the long term in patients with atopic dermatitis on maintenance therapy.
Managed Care Cast
August 6th 2025

Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH

Giuliana Grossi Anna Bobb, MPH
Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.
Large language models. | Image Credit: witsarut - stock.adobe.com
August 6th 2025

LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening

Cameron Santoro
Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
AJMC
August 6th 2025

Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021

Elise S. Tremblay, MD, MPH Stephanie Argetsinger, MS, MPH Fang Zhang, PhD Dennis Ross-Degnan, ScD J. Frank Wharam, MD, MPH
Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo